分散式臨床試驗：全球市場

本報告檢視了全球分散式臨床試驗市場，並提供了市場概況、市場影響因素和市場機會分析、技術趨勢、法律制度、市場規模趨勢和預測、按各個細分市場和地區進行的詳細分析以及主要企業的概況。

目錄

第1章執行摘要

• 市場展望
• 調查範圍
• 市場概況
• 概述
• 當前市場情勢
• 細分市場分析
• 區域分析
• 新興技術
• 結論

第2章 市場概覽

• 當前市場概況
• 宏觀經濟因素分析
• 人口統計因素
• 地緣政治因素
• 美國關稅的影響
• 波特五力分析

第3章 市場動態

• 市場動態
• 市場促進因素
• 呼籲改善病患就醫途徑及增加試驗多樣性
• 對分散式臨床試驗的有利監管支持
• 技術擴散和數位基礎設施
• 市場限制
• 資料完整性和安全性問題
• 營運和後勤複雜性
• 市場機遇
• 人工智慧與穿戴式科技的融合
• 將臨床研究擴展到服務不足和偏遠地區

第4章：監理現狀

• 概述
• 美國
• 歐洲
• 亞太地區

第5章 新興科技與發展

• 重點總結
• 下一代數位審判平台與整合生態系統
• 穿戴式裝置、遠端監測和數位生物標記物
• 自動化、人工智慧和預測性試驗管理
• 最佳化數位化患者和研究人員的工作流程

第6章 市場區隔分析

• 概述
• 細分市場分析
• 市場分析：透過研究設計
• 重點總結
• 干預試驗
• 觀察性測試
• 擴展訪問
• 市場分析：按治療應用分類
• 重點總結
• 瘤
• 心臟病
• 其他
• 依部署模式進行市場分析
• 重點總結
• 基於雲端的DCT平台
• 本地部署解決方案
• 按最終用戶分類的市場分析
• 重點總結
• 製藥和生物技術公司
• 合約研究組織（CRO）
• 其他
• 地理細分
• 按地區分類的市場分析
• 重點總結
• 北美洲
• 歐洲
• 亞太地區
• 其他地區

第7章 競爭訊息

• 重點總結
• 競爭分析
• 策略舉措
• M&A
• 合作

第8章附錄

• 調查方法
• 來源
• 簡稱
• 公司簡介
• CLARIO
• FORTREA
• ICON PLC
• LABCORP
• MEDABLE INC.
• MEDIDATA
• OBVIO HEALTH USA INC.
• PAREXEL INTERNATIONAL (MA) CORP.
• THERMO FISHER SCIENTIFIC INC.
• VEEVA SYSTEMS INC.

The report provides an overview of the global decentralized clinical trials (DCT) market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and for the forecast period 2025 through 2030.

Report Scope

This report analyzes the trends in the global market for decentralized clinical trials. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period of 2025 through 2030. The market is segmented by study design (interventional trials, observational trials and expanded access), by therapeutic application (oncology, cardiology and other areas) and by deployment mode (cloud-based decentralized clinical trial (DCT) platforms and on-premises solutions). End users include pharmaceutical and biotechnology companies, contract research organizations (CROs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies. It offers company profiles covering financials, product portfolios and recent developments.

Report Includes

• An overview of the global markets for decentralized clinical trials (DCT)
• An analysis of the global market trends with market revenue data from 2022- 2025, and projected CAGRs through 2030
• Estimates of the size and revenue prospects of the global market, along with a market share analysis by study design, therapeutic application, deployment mode, end user, and region
• Facts and figures pertaining to the market dynamics, technical advances, regulations, impact of macroeconomic factors, and R&D activities
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Company profiles

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Analysis
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Current Market Overview
• Macroeconomic Factors Analysis
• Demographic Factors
• Geopolitical Factors
• Impact of the U.S. Tariffs
• Porter's Five Forces Analysis
• Potential for New Entrants: Moderate
• Bargaining Power of Suppliers: Moderate
• Bargaining Power of Buyers: Moderate to High
• Threat of Substitute Products or Services: Low to Moderate
• Industry Competition: High

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Demand for Improved Patient Access and Trial Diversity
• Favorable Regulatory Support for Decentralized Clinical Trials
• Technological Proliferation and Digital Infrastructure
• Market Restraints
• Data Integrity and Security Concerns
• Operational and Logistical Complexities
• Market Opportunities
• Integration of Artificial Intelligence and Wearable Technologies
• Extending Clinical Research Reach to Underserved and Remote Areas

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologies and Developments

• Key Takeaways
• Next-Generation Digital Trial Platforms and Integrated Ecosystems
• Wearables, Remote Monitoring and Digital Biomarkers
• Automation, AI and Predictive Trial Management
• Digital Patient and Investigator Workflow Optimization

Chapter 6 Market Segmentation Analysis

• Overview
• Segmentation Breakdown
• Market Analysis by Study Design
• Key Takeaways
• Interventional Trials
• Observational Trials
• Expanded Access
• Market Analysis by Therapeutic Application
• Key Takeaways
• Oncology
• Cardiology
• Others
• Market Analysis by Deployment Mode
• Key Takeaways
• Cloud-Based DCT Platforms
• On-Premises Solutions
• Market Analysis by End User
• Key Takeaways
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Analysis
• Strategic Initiatives
• Mergers and Acquisitions
• Collaborations

Chapter 8 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• CLARIO
• FORTREA
• ICON PLC
• LABCORP
• MEDABLE INC.
• MEDIDATA
• OBVIO HEALTH USA INC.
• PAREXEL INTERNATIONAL (MA) CORP.
• THERMO FISHER SCIENTIFIC INC.
• VEEVA SYSTEMS INC.

List of Tables

• Summary Table : Global Market for Decentralized Clinical Trials, by Region, Through 2030
• Table 1 : Global Market for Decentralized Clinical Trials, by Study Design, Through 2030
• Table 2 : Global Market for Interventional Decentralized Clinical Trials, by Region, Through 2030
• Table 3 : Global Market for Observational Decentralized Clinical Trials, by Region, Through 2030
• Table 4 : Global Market for Expanded Access Decentralized Clinical Trials, by Region, Through 2030
• Table 5 : Global Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
• Table 6 : Global Market for Oncology in Decentralized Clinical Trials, by Region, Through 2030
• Table 7 : Global Market for Cardiology in Decentralized Clinical Trials, by Region, Through 2030
• Table 8 : Global Market for Other Therapeutic Applications in Decentralized Clinical Trials, by Region, Through 2030
• Table 9 : Global Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
• Table 10 : Global Market for Cloud-Based DCT Platforms in Decentralized Clinical Trials, by Region, Through 2030
• Table 11 : Global Market for On-Premises Solutions in Decentralized Clinical Trials, by Region, Through 2030
• Table 12 : Global Market for Decentralized Clinical Trials, by End User, Through 2030
• Table 13 : Global Market for Pharmaceutical and Biotechnology Companies in Decentralized Clinical Trials, by Region, Through 2030
• Table 14 : Global Market for CROs in Decentralized Clinical Trials, by Region, Through 2030
• Table 15 : Global Market for Other End Users in Decentralized Clinical Trials, by Region, Through 2030
• Table 16 : Global Market for Decentralized Clinical Trials, by Region, Through 2030
• Table 17 : North American Market for Decentralized Clinical Trials, by Study Design, Through 2030
• Table 18 : North American Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
• Table 19 : North American Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
• Table 20 : North American Market for Decentralized Clinical Trials, by End User, Through 2030
• Table 21 : European Market for Decentralized Clinical Trials, by Study Design, Through 2030
• Table 22 : European Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
• Table 23 : European Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
• Table 24 : European Market for Decentralized Clinical Trials, by End User, Through 2030
• Table 25 : Asia-Pacific Market for Decentralized Clinical Trials, by Study Design, Through 2030
• Table 26 : Asia-Pacific Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
• Table 27 : Asia-Pacific Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
• Table 28 : Asia-Pacific Market for Decentralized Clinical Trials, by End User, Through 2030
• Table 29 : RoW Market for Decentralized Clinical Trials, by Study Design, Through 2030
• Table 30 : RoW Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
• Table 31 : RoW Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
• Table 32 : RoW Market for Decentralized Clinical Trials, by End User, Through 2030
• Table 33 : Global Ranking of Companies in the Market for Decentralized Clinical Trials, 2024
• Table 34 : Mergers and Acquisitions in the Decentralized Clinical Trials Industry, 2025
• Table 35 : Collaborations in the Decentralized Clinical Trials Industry, 2023-2025
• Table 36 : Information Sources Used for this Report
• Table 37 : Abbreviations Used in this Report
• Table 38 : Clario: Company Snapshot
• Table 39 : Clario: Product Portfolio
• Table 40 : Clario: News/Key Developments, 2023-2025
• Table 41 : Fortrea: Company Snapshot
• Table 42 : Fortrea: Financial Performance, FY 2023 and 2024
• Table 43 : Fortrea: Product Portfolio
• Table 44 : Fortrea: News/Key Developments, 2023-2025
• Table 45 : ICON plc: Company Snapshot
• Table 46 : ICON plc: Financial Performance, FY 2023 and 2024
• Table 47 : ICON plc: Product Portfolio
• Table 48 : ICON plc: News/Key Developments, 2023-2025
• Table 49 : Labcorp: Company Snapshot
• Table 50 : Labcorp: Financial Performance, FY 2023 and 2024
• Table 51 : Labcorp: Product Portfolio
• Table 52 : Labcorp: News/Key Developments, 2022-2025
• Table 53 : Medable Inc.: Company Snapshot
• Table 54 : Medable Inc.: Product Portfolio
• Table 55 : Medable Inc.: News/Key Developments, 2023-2025
• Table 56 : Medidata: Company Snapshot
• Table 57 : Medidata: Product Portfolio
• Table 58 : Medidata: News/Key Developments, 2023-2025
• Table 59 : Obvio Health USA Inc.: Company Snapshot
• Table 60 : Obvio Health USA Inc.: Product Portfolio
• Table 61 : Obvio Health USA Inc.: News/Key Developments, 2023-2025
• Table 62 : Parexel International (MA) Corp.: Company Snapshot
• Table 63 : Parexel International (MA) Corp.: Product Portfolio
• Table 64 : Parexel International (MA) Corp.: News/Key Developments, 2024-2025
• Table 65 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 66 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
• Table 67 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 68 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023-2025
• Table 69 : Veeva Systems Inc.: Company Snapshot
• Table 70 : Veeva Systems Inc.: Financial Performance, FY 2023 and 2024
• Table 71 : Veeva Systems Inc.: Product Portfolio
• Table 72 : Veeva Systems Inc.: News/Key Developments, 2025

List of Figures

• Summary Figure : Global Market Shares for Decentralized Clinical Trials, by Region, 2024
• Figure 1 : Porter's Five Forces Analysis of the Market for Decentralized Clinical Trials
• Figure 2 : Snapshot of the Market Dynamics for Decentralized Clinical Trials
• Figure 3 : Global Market Shares for Decentralized Clinical Trials, by Study Design, 2024
• Figure 4 : Global Market Shares for Decentralized Clinical Trials, by Therapeutic Application, 2024
• Figure 5 : Global Market Shares for Decentralized Clinical Trials, by Deployment Mode, 2024
• Figure 6 : Global Market Shares for Decentralized Clinical Trials, by End User, 2024
• Figure 7 : Global Market Shares for Decentralized Clinical Trials, by Region, 2024
• Figure 8 : ICON plc: Revenue Shares, by Country/Region, FY 2024
• Figure 9 : Labcorp: Revenue Shares, by Business Unit, FY 2024
• Figure 10 : Labcorp: Revenue Shares, by Country/Region, FY 2024
• Figure 11 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 12 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 13 : Veeva Systems Inc.: Revenue Shares, by Country/Region, FY 2024